Home > Healthcare > Medical Devices > Diagnostic Devices > preventive healthcare technologies and services market
Get a free sample of Preventive Healthcare Technologies and Services Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Preventive Healthcare Technologies and Services Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Preventive Healthcare Technologies and Services Market size was valued at USD 251.2 billion in 2023 and is set to grow at 10.3% CAGR from 2024 to 2032.These services refer to a range of medical tools, interventions, strategies, and healthcare practices that are designed to prevent the onset or progression of diseases before they become more serious or require more extensive treatment.
The prevalence of chronic diseases, such as diabetes and obesity, has surged demand for these preventive services. For instance, according to WHO, chronic diseases are the leading cause of death globally, accounting for nearly 71% of all deaths worldwide. Thus, preventive measures help to mitigate the risk and reduce the impact of these conditions thereby accelerating the market progress.
Rising number of government awareness programs has increased popularity of preventive healthcare over the last decade. The Patient Protection and Affordable Care Act, commonly known as Obamacare, was enacted in 2010 and has mandated the inclusion of preventive healthcare services by insurance providers at no additional cost until now. Therefore, the private insurance companies are also currently shifting their focus on this market due to its enormous potential.
GlaxoSmithKline, Omnicell, Inc, Myriad Genetics, Omron Healthcare, Abbott Laboratories, Medtronic, Quest Diagnostics, Merck & Co. Inc., Sanofi, NOVX Systems Corp and Moderna, Inc. are some of the key preventive healthcare technologies and service providers.
U.S. preventive healthcare technologies and services industry size was USD 70.9 billion in 2022 and is predicted to witness substantial growth through 2032 owing to rising technological advancements and substantial healthcare expenditure.
Preventive healthcare technologies and services industry size was USD 251.2 billion in 2023 and is estimated to reach USD 605.3 billion by 2032 owing to the growing prevalence of chronic diseases, such as diabetes and obesity.
The hospitals end-use segment held over 41% of the preventive healthcare technologies and services industry share in 2022 propelled by the strong presence of skilled healthcare professionals.